This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Birner, A. M. Articles by Ernstoff, M. S. Search for Related Content PubMed Articles by Birner, A. M. Articles by Ernstoff, M. S.

Program to Support Safe Administration of Oral Chemotherapy

Dartmouth-Hitchcock Medical Center, Lebanon, NH

Corresponding author: Ann M. Birner, PharmD, BCOP, Pharmacy Department, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, ann.birner@hitchcock.org

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Drugs, particularly direct cytotoxics, prescribed for the treatment of patients with cancer often are characterized by their narrow therapeutic indices. During the last decade, the medical literature has been replete with evidence of heightened concern regarding chemotherapy safety.^1-10 Numerous institutions, including ours, have thoroughly reviewed and subsequently revised chemotherapy policies and procedures to improve medication safety and elevate the standard of care.^3,6,11 The resultant improvements typically have taken place in the inpatient and clinic settings, where chemotherapy administration is managed entirely by health care professionals. Chemotherapy process improvements at Dartmouth-Hitchcock Medical Center (DHMC; Lebanon, New Hampshire) during the late 1990s . . . [Click for More]

This article has been cited by other articles:

				P. Legant Oncologists and Medical Malpractice J. Oncol. Pract, July 1, 2006; 2(4): 164 - 169. [Full Text] [PDF]